The scientific response to TB – the other deadly global health emergency

por Chaisson, R. E., Frick, M., Nahid, P.
Publicado 2022

A comparison of clinical development pathways to advance tuberculosis regimen development

por Chang, V., Phillips, P. P. J., Imperial, M. Z., Nahid, P., Savic, R. M.
Publicado 2022

A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials

por Hills, N. K., Lyimo, J., Nahid, P., Savic, R. M., Lienhardt, C., Phillips, P. P. J.
Publicado 2021

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trials

por Savic, RM, Weiner, M, MacKenzie, WR, Engle, M, Whitworth, WC, Johnson, JL, Nsubuga, P, Nahid, P, Nguyen, NV, Peloquin, CA, Dooley, KE, Dorman, SE
Publicado 2017

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis

por Nahid, P., Jarlsberg, L. G., Kato-Maeda, M., Segal, M. R., Osmond, D. H., Gagneux, S., Dobos, K., Gold, M., Hopewell, P. C., Lewinsohn, D. M.
Publicado 2018

WHO target product profiles for TB preventive treatment

por Den Boon, S., Lienhardt, C., Zignol, M., Schwartzman, K., Arinaminpathy, N., Campbell, J. R., Nahid, P., Penazzato, M., Menzies, D., Vesga, J. F., Oxlade, O., Churchyard, G., Merle, C. S., Kasaeva, T., Falzon, D.
Publicado 2022

Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring

por Huddart, S., Asege, L., Jaganath, D., Golla, M., Dang, H., Lovelina, L., Derendinger, B., Andama, A., Christopher, D. J., Nhung, N. V., Theron, G., Denkinger, C. M., Nahid, P., Cattamanchi, A., Yu, C.
Publicado 2023

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial

por Sigal, G.B., Segal, M.R., Mathew, A., Jarlsberg, L., Wang, M., Barbero, S., Small, N., Haynesworth, K., Davis, J.L., Weiner, M., Whitworth, W.C., Jacobs, J., Schorey, J., Lewinsohn, D.M., Nahid, P.
Publicado 2017

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure

por Jayakumar, A., Savic, R. M., Everett, C. K., Benator, D., Alland, D., Heilig, C. M., Weiner, M., Friedrich, S. O., Martinson, N. A., Kerrigan, A., Zamudio, C., Goldberg, S. V., Whitworth, W. C., Davis, J. L., Nahid, P.
Publicado 2016

Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomize...

por Patil, S. B., Tamirat, M., Khazhidinov, K., Ardizzoni, E., Atger, M., Austin, A., Baudin, E., Bekhit, M., Bektasov, S., Berikova, E., Bonnet, M., Caboclo, R., Chaudhry, M., Chavan, V., Cloez, S., Coit, J., Coutisson, S., Dakenova, Z., De Jong, B. C., Delifer, C., Demaisons, S., Do, J. M., Dos Santos Tozzi, D., Ducher, V., Ferlazzo, G., Gouillou, M., Khan, U., Kunda, M., Lachenal, N., LaHood, A. N., Lecca, L., Mazmanian, M., McIlleron, H., Moreau, M., Moschioni, M., Nahid, P., Osso, E., Oyewusi, L., Panda, S., Pâquet, A., Thuong Huu, P., Pichon, L., Rich, M. L., Rupasinghe, P., Salahuddin, N., Sanchez Garavito, E., Seung, K. J., Velásquez, G. E., Vallet, M., Varaine, F., Yuya-Septoh, F. J., Mitnick, C. D., Guglielmetti, L.
Publicado 2023